X-ZELL Blog Episode 5

The role of magnetic resonance imaging (MRI) as a tool to detect and stage clinically significant prostate cancer (csPCa) continues to cause controversy among the medical community.The 19th Asia-Pacific Prostate Cancer Conference (APCC) held in Brisbane last month...

X-ZELL Blog Episode 4

Friday, 24 August 2018, will go down as a decisive milestone in the history of X-ZELL Inc. – not just because we had the privilege of sharing our latest research with the global scientific community, but also because we had a chance to showcase just how perfectly our...

X-ZELL Blog Episode 3

Even though the notion of discovering prostate cancer early may seem intriguing from a patient perspective, the topic has been dividing the medical community for decades. The sticking point is a simple question – how early is too early? While many a patient would...

X-ZELL Blog Episode 2

Last month, X-ZELL CEO, Dr Sebastian Bhakdi, used his guest speaking spot at the 2018 HealthInvestor Asia Summit to reflect on the opportunities and challenges biotechnology start-ups face in Asia – revealing why so many of them fail to go all the way from ideation to...

X-ZELL Blog Episode 1

Often underestimated, prostate cancer continues to be a significant threat to men’s health. An estimated 1.1 million men worldwide are diagnosed with the disease every year, some 400,000 die of it. That’s about 45 men every hour, every day. And the numbers are rising....



© 2020 X-ZELL INC

Find Us